Giant Abdominal Wall Desmoid Tumor with Mass Effect: A Case Report and Review of the Literature

Main Article Content

Djelti Sihem
Boudraa Skander
Benmoumen Yassine

Abstract

Desmoid tumors, or aggressive fibromatoses, are rare fibroblastic proliferations of soft tissues. Although benign from a metastatic standpoint, they possess a high potential for local invasion. Giant forms, inducing a compressive mass effect, pose complex therapeutic challenges. This case report highlights the critical decision-making process in giant abdominal wall desmoid tumors where immediate salvage surgery takes precedence over conservative active surveillance due to severe symptoms and tissue compression. We report the case of a 46-year-old female patient presenting with a large mass on the abdominal wall evolving over 6 months, causing chronic pain, functional impairment, and a significant mass effect on adjacent pelvic structures. Magnetic resonance imaging (MRI) revealed a large infiltrating tissue lesion. Biopsy and immunohistochemistry confirmed the diagnosis of aggressive fibromatosis. Given the significant mass effect, wide surgical excision with tumor-free margins was performed. The postoperative course was uneventful, with no local recurrence at the 6-month follow-up.
Conclusion: The management of giant desmoid tumors with mass effect requires a personalized, multidisciplinary approach, oscillating between monitoring, medical alternatives, and salvage surgery.

Downloads

Download data is not yet available.

Article Details

Sihem, D., Skander, B., & Yassine, B. (2026). Giant Abdominal Wall Desmoid Tumor with Mass Effect: A Case Report and Review of the Literature. Global Journal of Medical and Clinical Case Reports, 13(9), 199–201. https://doi.org/10.17352/gjmccr.000268
Case Reports

Copyright (c) 2026 Sihem D, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Desmoid Tumor Working Group. The management of desmoid tumors: A joint global consensus-based guideline approach for adult and pediatric patients.Eur J Cancer2020;127:96-107. Available from: https://doi.org/10.1016/j.ejca.2019.11.013 DOI: https://doi.org/10.1016/j.ejca.2019.11.013

Kasper B, Baumgarten C, Garcia J, Bonvalot S, Hoekstra HJ. An update on the management of desmoid-type fibromatosis: On behalf of the European Organization for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.Eur J Cancer2017;80:89-98. Available from: https://doi.org/10.1093/annonc/mdx323 DOI: https://doi.org/10.1093/annonc/mdx323

Penel N, Chibon F, Salas S. Management of desmoid tumors: A large national retrospective study of 771 patients by the French Sarcoma Group.Ann Oncol2019;30(2):241-248.

Bassan F, Dupuis O, Lardy H. Management of desmoid tumors: Paradigm change and new recommendations.J Chir Visc2020;157(4):285-292.

Salas S, Kaur A, Liang X, Blay JY. Abdominal wall desmoid tumors: Surgical outcomes and risk of recurrence in a cohort of 142 patients.World J Surg2018;42(9):2810-2818.